Skip to main content
Medical information Clinical review pending

Gastroenterology Testing

Hepatitis Be Panel Test

The Hepatitis Be Panel Test helps assess liver health and detect hepatitis B virus activity. It measures specific markers in the blood to indicate infection and immune response, crucial for individuals at risk of liver disorders.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (serum).
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. Generally, no special preparation is required, but fasting may be requested.
Test priceKSh 3,510

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Hepatitis Be Panel Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals experiencing symptoms like jaundice, fatigue, or abdominal pain.
  • ✓People with a history of intravenous drug use.
  • ✓Individuals with a history of unprotected sex.
  • ✓Those exposed to blood products.
  • ✓People with a family history of liver disease.
  • ✓Monitoring of patients with known hepatitis B infection.
02

In plain language

What this test helps you understand

This test is used to diagnose hepatitis B infection, assess the level of viral activity, determine the risk of transmission, and monitor the effectiveness of treatment.
The Hepatitis Be Panel Test is a vital diagnostic tool used to evaluate the presence of the hepatitis B virus (HBV) in the bloodstream. This test is essential for diagnosing hepatitis B infections and monitoring liver health. Hepatitis B can lead to chronic liver disease, making early detection crucial for effective management and treatment.

The test measures two key components in the blood: Anti-HBe and HBeAg. Anti-HBe indicates the immune response to the virus, suggesting whether it is active or inactive. HBeAg indicates active viral replication and helps assess the level of infectiousness.

Interpreting your test results is essential for understanding your health status. A positive HBeAg result may indicate active hepatitis B infection, while a positive Anti-HBe result suggests the immune system is responding. Always consult with a healthcare provider for a thorough interpretation of your results.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Generally, no special preparation is required, but fasting may be requested.
SampleBlood sample (serum).
MethodologyImmunoassay (e.g., ELISA or Chemiluminescence). Confirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects specific markers of hepatitis B. It does not detect other types of hepatitis or liver diseases. Results must be interpreted by a qualified healthcare professional.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The test measures two key markers: HBeAg (hepatitis B e antigen) and Anti-HBe (antibody to hepatitis B e antigen). These help determine if the hepatitis B virus is active and replicating.
Individuals with symptoms of liver disease, those at high risk (e.g., history of IV drug use, unprotected sex), people with family history of liver disease, and those needing monitoring for existing infection should consider this test.
A positive HBeAg result generally indicates that the hepatitis B virus is actively replicating in the body and the person may be highly infectious.
A positive Anti-HBe result usually suggests that the immune system is responding to the virus, and viral replication may be decreasing. However, interpretation requires clinical context.
Turnaround time varies. Please confirm the specific turnaround time with the laboratory before booking your test.
You can book your test by calling or WhatsApping us at +254711564616. We have branches in major cities and offer home sample collection.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp